Richiedi una copia del documento: RANDOMIZED TRIAL OF TWO SCHEDULES OF LOW-DOSE GEMTUZUMAB OZOGAMICIN AS INDUCTION MONOTHERAPY FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKAEMIA IN OLDER PATIENTS NOT CONSIDERED CANDIDATES FOR INTENSIVE CHEMOTHERAPY. A PHASE II STUDY OF THE EORTC AND GIMEMA LEUKAEMIA GROUPS (AML-19)

Captcha code
Annulla